About Ascribe Bioscience
Ascribe Bioscience is a private company based in Ithaca, New York, incorporated in 2021 in Delaware. It has reported $22,854,023 raised in four offerings on Form D since September 2021. Its chief executive is Jay Farmer.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 8, 2025 | Oct 15, 2025 | $15,019,027of $15.2M target | 11 | $1.3M | Equity, OptionsRule 506(b) | Form D ↗ |
| Oct 1, 2024 | Oct 7, 2024 | $2,150,000fully sold | 5 | $430K | OptionsRule 506(b) | Form D ↗ |
| Jul 29, 2022 | Aug 3, 2022 | $3,184,996of $3.2M target | 7 | $454K | EquityRule 506(b) | Form D ↗ |
| Aug 27, 2021 | Sep 15, 2021 | $2,500,000fully sold | 12 | $208K | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $22,854,023 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Ascribe Bioscience's Form D filed Oct 15, 2025.
AB
Alex Bondar
Director
FG
Fred Gruis
Director
FS
Frank Schroeder
Director
JF
Jay Farmer
CEO and director
KW
Kyle Welborn
Director